Newsfeeds Archive - Page 79 of 211

1 minute read

Aspen Group Q2 EPS $(0.09) Misses $(0.06) Estimate, Sales $17.07M Beat $15.55M Estimate

December 13, 5:03 PM

Aspen Group (NASDAQ:ASPU) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.06) by 50 percent. This is a 18.18 percent increase over losses of $(0.11) per share from the

ASPU

1 minute read

Coty Says Entered Into Agreements With Several Banks To Start Hedging Planned Share Buyback Program Of ~$200M In Calendar 2025,

By Michael Horton

December 12, 6:37 PM

Coty Inc. (NYSE:COTY) today announced it is entering into agreements with several banks to start hedging a planned share buyback program of approximately $200 million in calendar 2025. This program adds to the

COTY

2 minute read

Alexander & Baldwin Promotes Lance Parker To President, Chief Operating Officer

By Michael Horton

December 12, 6:34 PM

Alexander & Baldwin, Inc. (NYSE:ALEX) ("A&B" or "Company"), a premier Hawai'i commercial real estate company, today announced the appointment of Lance K. Parker, currently the

ALEX

3 minute read

Nurix Therapeutics Presents Clinical Results From Novel BTK Degrader (NX-2127) At 64th American Society Of Hematology (ASH) Annual Meeting

By Michael Horton

December 12, 6:33 PM

Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with hematologic malignancies and solid tumors, today presented

NRIX

3 minute read

Regeneron Pharmaceuticals Says Odronextamab (CD20xCD3) Demonstrates High, Durable Complete Response Rate Among Patients With Relapsed/Refractory Follicular Lymphoma In Phase 2 Trial

By Michael Horton

December 12, 6:32 PM

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced positive first data from a cohort of a pivotal Phase 2 trial evaluating investigational odronextamab in patients with heavily pre-treated, relapsed/refractory

REGN

1 minute read

FDA
News

Mirati Therapeutics Shares Move Higher, FDA Website Shows Approval Of Krazati (adagrasib)

By Michael Horton

December 12, 6:28 PM

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216340

MRTX

1 minute read

News

First Solar Set To Join S&P 500 Replacing Fortune Brands Home & Security; Fortune Brands To Replace First Solar In S&P MidCap 400; MasterBrand To Replace Conn’s In S&P SmallCap 600

By Michael Horton

December 12, 6:23 PM

S&P MidCap 400 constituent First Solar Inc. (NASD: FSLR) will replace Fortune Brands Home & Security Inc. (NYSE:FBHS) in the S&P 500, Fortune Brands Innovations Inc. (NYSE:FBIN) will replace First Solar in

CONN

1 minute read

Oracle Says Expects Q3 Revenue Growth Of 21%-23% In Constant Currency

By Michael Horton

December 12, 6:21 PM

-Reuters Citing Conference Call

ORCL

1 minute read

Fluence Energy Q4 EPS $(0.32) Misses $(0.28) Estimate, Sales $441.98M Beat $347.07M Estimate

By Michael Horton

December 12, 6:16 PM

Fluence Energy (NASDAQ:FLNC) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.28) by 14.29 percent. This is a 146.15 percent decrease over losses of $(0.13) per share from

FLNC

1 minute read

Oracle Says Expect Organic Growth For FY23 Cloud Revenue Will Be Over 30% In Constant Currency

By Michael Horton

December 12, 6:12 PM

-Reuters Citing Conference Call

ORCL